HAX Demo Day!! In Newark + Virtual. May 1. Register Now.

Brain stimulation wearable and app-based therapy to treat clinical depression

GET CONNECTED
flowneuroscience.com

Team

Daniel Mansson

CCO & Co-Founder

Erik Rehn

CTO & Co-Founder

Erin Lee

CEO

Flow Neuroscience

Company details

Flow Neuroscience offers a medication-free depression treatment that combines a brain stimulation wearable and an app-based therapy program.

Human HealthNeurotechSwedenSeries A(+)Hard TechHealthcareHuman HealthMental HealthHAX 10

Company News

Samphire Neuroscience secures $2.3M Pre-Seed to launch menstrual health wearable

February 23, 2024
Tech.eu

Could a brain-stimulating headset assist in treating depression? – The Irish Independent

January 10, 2024
Independent.ie

Headset delivers electric current to ease depression at home | New Scientist

December 29, 2023
New Scientist

NHS trials headset that claims to zap depression | News – The Times

January 23, 2023
The Times

tDCS, tACS and tRNS Market to Deliver Prominent Growth & Striking Opportunities Scenario …

June 12, 2022
newsorigins.com

Get In Touch with Flow Neuroscience

Please tell us a little bit about yourself and why you'd like to get connected. Flow Neuroscience + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More